In addition CD36 and LACS can be considered as potential therapeutic targets to treat AD, bipolar disorders or Refsum disease (RfD), which is an autosomal recessive neurologic disorder of the lipid metabolism. The gene discussed is ACSL1; the disease is bipolar disorder.